AngioDynamics (NASDAQ:ANGO) reported Q2 2018 earnings this Morning, coming in at $0.16 per share, in-line Wall Street’s estimates of $0.16 per Share. Revenue for the quarter came in at $86.70 million missing the streets estimates of $88.15 million Recent Insider Trading for AngioDynamics (NASDAQ:ANGO)
- On 7/24/2017 Jan Stern Reed, Director, bought 316 with an average share price of $16.00 per share and the total transaction amounting to $5,056.00.
- On 7/21/2017 James C Clemmer, CEO, bought 5,000 with an average share price of $15.79 per share and the total transaction amounting to $78,950.00.
- On 7/20/2017 James C Clemmer, CEO, bought 20,000 with an average share price of $15.64 per share and the total transaction amounting to $312,800.00.
- On 4/12/2017 Avista Capital Partners Gp, Ll, Major Shareholder, sold 2,350,000 with an average share price of $16.00 per share and the total transaction amounting to $37,600,000.00.
- On 8/5/2016 Avista Capital Partners Gp, Ll, Major Shareholder, sold 2,241,000 with an average share price of $14.62 per share and the total transaction amounting to $32,763,420.00.
- On 8/5/2016 David F Burgstahler, Director, sold 2,250,000 with an average share price of $14.62 per share and the total transaction amounting to $32,895,000.00.
Recent Trading for AngioDynamics (NASDAQ:ANGO) Shares of AngioDynamics closed the previous trading session at 16.41 +0.00 0.00% with shares trading hands.